---
title: "I-Mab (now NovaBridge Biosciences) regains Nasdaq minimum bid price compliance"
url: "https://aibio.space/news/i-mab-now-novabridge-biosciences-regains-nasdaq-minimum-bid-price/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-06-12"
section: "Listings"
tickers: "NASDAQ:NBP"
source: "https://www.sec.gov/Archives/edgar/data/1778016/000095017025085117/imab-ex99_1.htm"
summary: "Nasdaq notified the company on June 11, 2025. Its American Depositary Shares will stay listed and traded on Nasdaq."
---

By the aibio.space news desk.

Sources

- [NovaBridge Biosciences 6-K (2025-06-12)](https://www.sec.gov/Archives/edgar/data/1778016/000095017025085117/imab-ex99_1.htm)

[NBP](https://aibio.space/companies/novabridge-biosciences/)

2025-06-12

# I-Mab (now NovaBridge Biosciences) regains Nasdaq minimum bid price compliance

Tickers [NBP](https://aibio.space/companies/novabridge-biosciences/)

Nasdaq notified the company on June 11, 2025. Its American Depositary Shares will stay listed and traded on Nasdaq.

## Key facts

- **Company**: NovaBridge Biosciences (NASDAQ: NBP)

- **News type**: Listings

- **Primary source**: [NovaBridge Biosciences 6-K (2025-06-12)](https://www.sec.gov/Archives/edgar/data/1778016/000095017025085117/imab-ex99_1.htm)

*The stone facade of a federal building. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

I-Mab (now NovaBridge Biosciences) (NASDAQ: IMAB) announced on June 12, 2025 that it received notification on June 11, 2025 from The Nasdaq Stock Market LLC that it had regained compliance with Nasdaq's $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

The company's American Depositary Shares (ADSs) will continue to be listed and traded on Nasdaq. ADSs are U.S.-traded shares that represent ordinary shares of a company based abroad.

To regain compliance, the ADSs were required to hold a minimum closing bid price of $1.00 for at least 10 consecutive business days. The company said that was achieved on June 10, 2025. Nasdaq has stated that the matter is now closed. The bid price is the price buyers offer for a share. The company disclosed the notice in a Form 6-K with a press release dated June 12, 2025.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

NBP

NovaBridge Biosciences

NASDAQ · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/i-mab-now-novabridge-biosciences-regains-nasdaq-minimum-bid-price/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "I-Mab (now NovaBridge Biosciences) regains Nasdaq minimum bid price compliance", 2025-06-12, https://aibio.space/news/i-mab-now-novabridge-biosciences-regains-nasdaq-minimum-bid-price/